Olutasidenib Capsules for Acute Myeloid Leukemia - A Comprehensive Overview
Adults with AML who carry a specific gene mutation known as isocitrate dehydrogenase-1 (IDH 1) are treated with Olutasidenib.
Novel Mutations in AML - An Insight
The treatment of leukemia is changing due to novel mutations in AML that drive individualized care, enlighten prognosis, and motivate targeted medicines.
Vitamin Supplementation and AML Treatment Outcomes
Vitamin supplementation and AML treatment outcomes are discussed in the literature to be concerned with.
